{"url_path":"/sec/bngo/8-k/2026-06-24/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000040-index.html","accession_number":"0001411690-26-000040","cik":"0001411690","ticker":"BNGO","issuer_name":"Bionano Genomics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000040-index.html","primary_entity_key":"0001411690","primary_entity_name":"Bionano Genomics, Inc."},"word_count":64,"has_tables":true,"body_markdown":"Item 8.01.\n\nOther Events.\n\n \n\nAppointment of Chief Scientific Officer\n\n \n\nOn June 24, 2026, Bionano Genomics, Inc. (the “Company”) issued a press release announcing the hiring of Alex Hastie, Ph.D. as the Chief Scientific Officer of the Company effective July 20, 2026, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein."}